Vialwirebiotech, curated
November 21, 2026, 8:54 AM
October 12, 2026
- 9:43 AM · PharmaVoice9:43 AMLilly is fighting a black market for its new obesity drug even before it launches — PharmaVoice
- 9:38 AM · Pharmaceutical Executive9:38 AM<![CDATA[Bausch + Lomb Appoints Thomas Appio as Interim CEO ]]> — Pharmaceutical Executive
- 6:48 AM · Pharmaceutical Technology6:48 AMFDA approves Teva’s monthly injection of olanzapine for schizophrenia — Pharmaceutical Technology
- 4:13 AM · Pharmaceutical Technology4:13 AMPerceptive, Nucleus partner to support radiopharmaceutical development — Pharmaceutical Technology
October 11, 2026
- 8:00 PM · Nature Biotechnology8:00 PMFDA nod for rare neurology drug — Nature Biotechnology